Andrew Huberman Joins Hims & Hers Board to Guide Consumer-Health Strategy

Andrew Huberman, a well-known neurobiology professor and host of the popular Huberman Lab podcast, is stepping into a significant role in the consumer-health industry. Huberman has joined the board of Hims & Hers, a company expanding its health offerings.

Huberman will provide science and brand marketing advice to the telehealth company. He will also support marketing efforts through his podcast. Huberman assured Business Insider that his content will remain unbiased, stating, “We will never filter information differently because of a brand relationship.”

Hims & Hers’ board includes notable members like former Netflix CFO David Wells. The company is extending its services beyond hair loss and erectile dysfunction treatments to include weight loss, preventive care, and peptides. The partnership aligns with the growing trend among telehealth companies to offer personalized healthcare solutions. Huberman emphasizes the importance of accessible healthcare, aiming to bridge the gap between traditional healthcare systems and high-end concierge care.

Over the past months, Huberman and Hims CEO Andrew Dudum discussed ways to make healthcare accessible worldwide. Huberman highlights the potential for personalized care to reach “the middle 95%” who may find it challenging to access adequate healthcare services.

“How do you empower the masses around the globe to feel better and take more agency in their life?” Dudum asked, reflecting their joint vision.

Hims is betting on optimization within science and regulation, such as testosterone and peptides. Huberman’s influence comes alongside Hims’ focus on expanding into areas like pain management and longevity.

Huberman expressed his interest in Hims’ commitment to handle peptide manufacturing from start to finish. He stated, “You have to be a channel, not a dam to this kind of information.” Dudum echoed this sentiment, emphasizing careful navigation in personalized health and longevity.

The robustness of Huberman’s podcast, with over 8 million subscribers, underscores its broad reach. Huberman ensured that his educational content would be independent of any product or platform affiliations. Although Huberman didn’t elaborate on how he will disclose his board role and marketing links with Hims in each podcast episode, his media company, Scicomm Media, will run Hims & Hers ads, receiving compensation.

The collaboration aims to offer consumers more structured health information. Huberman concludes that the initiative “really turns people into scientists of themselves.” The challenge is maintaining the rigor of information while also promoting the company’s services.